Dextera Surgical, Inc. (NASDAQ:DXTR) Files An 8-K Unregistered Sales of Equity Securities
Item 3.02. Unregistered Sales of Equity Securities.

On May 15, 2017, Broadfin Healthcare Master Fund, Ltd. provided notices converting 98,752 shares of Series A convertible preferred stock of Dextera Surgical, Inc. (the “Company”) into 987,520 shares of the Company’s Common Stock, and Camber Capital Master Fund, LP and two of its related entities provided notices converting an aggregate of 46,388 shares of the Company’s Series A convertible preferred stock into 463,880 shares of the Company’s Common Stock. These conversions are exempt from registration to Section 3(a)(9) of the Securities Act of 1933, as amended.

About Dextera Surgical, Inc. (NASDAQ:DXTR)

Dextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.

Dextera Surgical, Inc. (NASDAQ:DXTR) Recent Trading Information

Dextera Surgical, Inc. (NASDAQ:DXTR) closed its last trading session up +0.004 at 0.220 with 873,986 shares trading hands.